Police at UT Austin Had the Perfect Response to a Pro-Hamas Activist Flipping...
Secret Service Agent Assigned to Kamala Harris Suffers What Looks Like a Mental...
Here's the Video Exposing What NYU's Pro-Hamas Students Really Think
Will Jewish Voters Stop Voting For The Democrats Who Want To Kill Them?
Is Biden Serious With His Victory Lap on 'National Security'?
Someone Has to Be the Adult in the Room: Clear the Quad and...
Our Gallows Hill — The Latest Trump Witch Trial
‘Hush Money’ Case Against Trump Is Bad On The Law and On the...
Stop the 'Emergency Spending' Charade Already
Joe Biden’s Hitler Problem
Universities of America You Are Directly Responsible for the Rise of Jew Hatred...
The 'Belongers', Part II
Banning TikTok a Blow to Free Speech
Human Dreck
Border Crisis Solution - Forget Biden and Speaker Johnson
Tipsheet

Meet the First Recipients of the Pfizer Vaccine

AP Photo/Richard Drewm Fuke

Margaret Keenan, a 90-year-old grandmother who turns 91 next week, became the first person to receive a dose of the Pfizer vaccine on Tuesday. She was given the shot at the UK's University Hospital Coventry at 6:31 a.m. She said she felt "so privileged to be the first person vaccinated against COVID-19."

Advertisement

"It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year," Keenan remarked.

Here in the U.S., the FDA is meeting on Thursday to discuss Pfizer's emergency authorization request. In clinical trials, the Pfizer vaccine candidate, which was developed in partnership with BioNTech, proved to be 95 percent effective and with "no serious safety concerns," a company statement read.

"The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform," the FDA's agenda for Thursday reads. "On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older."

A second candidate, developed by Moderna, was over 94 percent effective. They too have requested an emergency authorization and the FDA will be meeting about that vaccine on Dec. 17.

Advertisement

"I think there's every chance that we will look back on...(Tuesday) as marking a decisive turning point in the battle against coronavirus," Simon Stevens, the CEO of England's National Health Service, said after the first dose was administered.

By the way, the second person to get a dose of the Pfizer vaccine in the UK is an 81-year-old man named William Shakespeare. Seriously.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement